Antioxidant and Anti-Inflammatory Effects of Coenzyme Q10 Supplementation on Infectious Diseases
- PMID: 35326965
- PMCID: PMC8953254
- DOI: 10.3390/healthcare10030487
Antioxidant and Anti-Inflammatory Effects of Coenzyme Q10 Supplementation on Infectious Diseases
Abstract
With the appearance of new viruses and infectious diseases (ID) such as COVID-19 in 2019, as well as the lack of specific pharmacological tools for the management of patients with severe complications or comorbidities, it is important to search for adjuvant treatments that help improve the prognosis of infectious disease patients. It is also important that these treatments limit the oxidative and hyperinflammatory damage caused as a response to pathogenic agents, since, in some cases, an inflammatory syndrome may develop that worsens the patient's prognosis. The potential benefits of complementary nutrients and dietary interventions in the treatment of pathological processes in which oxidative stress and inflammation play a fundamental role have been widely evaluated. Coenzyme Q10 (CoQ10) is a supplement that has been shown to protect cells and be effective in cardiovascular diseases and obesity. Additionally, some studies have proposed it as a possible adjuvant treatment in viral infections. Preclinical and clinical studies have shown that CoQ10 has anti-inflammatory and antioxidant effects, and effects on mitochondrial dysfunction, which have been linked to the inflammatory response.
Keywords: CoQ10; antioxidant; infectious disease; inflammation and immunomodulator; ubiquinone.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Quinzii C.M., Lopez L.C., Von-Moltke J., Naini A., Krishna S., Schuelke M., Salviati L., Navas P., DiMauro S., Hirano M. Respiratory chain dysfunction and oxidative stress correlate with severity of primary COQ10 deficiency. FASEB J. 2008;22:1874–1885. doi: 10.1096/fj.07-100149. - DOI - PMC - PubMed
-
- Gutierrez-Mariscal F.M., Arenas-de Larriva A.P., Limia-Perez L., Romero-Cabrera J.L., Yubero-Serrano E.M., López-Miranda J. Coenzyme Q10 Supplementation for the Reduction of Oxidative Stress: Clinical Implications in the Treatment of Chronic Diseases. Int. J. Mol. Sci. 2020;21:7870. doi: 10.3390/ijms21217870. - DOI - PMC - PubMed
-
- Yusuf S., Hawken S., Ôunpuu S., Dans T., Avezum A., Lanas F., McQueen M., Budaj A., Pais P., Varigos J., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet. 2004;364:937–952. doi: 10.1016/S0140-6736(04)17018-9. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
